Takanobu Motoshima
Kumamoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Robot-assisted laparoscopic nephrectomy for fish bone-induced perforation from the descending colon into a renal cyst: A case report.
Journal: Urology case reports
Published: January 15, 2026
Predictive Model of Objective Response to Nivolumab Monotherapy for Advanced Renal Cell Carcinoma by Machine Learning Using Genetic and Clinical Data: The SNiP-RCC Study.
Journal: JCO clinical cancer informatics
Published: April 25, 2025
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in Japan.
Journal: International journal of clinical oncology
Published: March 29, 2025
Aging potentially reduces CD169 expression in sinus macrophages of pelvic lymph nodes.
Journal: Medical molecular morphology
Published: January 08, 2025
Effectiveness and Safety of Second-line Tyrosine Kinase Inhibitors After Discontinuation of First-line Immune-oncology Combination Therapy Because of Adverse Events in the Patients With Metastatic Renal Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: December 28, 2024
HIF1α Plays a Crucial Role in the Development of TFE3-Rearranged Renal Cell Carcinoma by Orchestrating a Metabolic Shift Toward Fatty Acid Synthesis.
Journal: Genes to cells : devoted to molecular & cellular mechanisms
Published: December 04, 2024
ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell Carcinoma.
Journal: Current issues in molecular biology
Published: October 24, 2024
Immunohistochemical Analysis of a1-Acid Glycoprotein and Tumor Associated Macrophages in Clear Cell Renal Cell Carcinoma.
Journal: Cancer genomics & proteomics
Published: October 14, 2024
Potential protumor function of CD74 in clear cell renal cell carcinoma.
Journal: Human cell
Published: March 12, 2024
The contribution of the CRP/CD64 axis to renal cancer progression by inducing protumor activation of tumor-associated macrophages.
Journal: Clinical & translational immunology
Published: February 13, 2024
Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data.
Journal: Clinical genitourinary cancer
Published: February 05, 2024
The efficacy of second-line tyrosine kinase inhibitor for patients with metastatic non-clear cell renal cell carcinoma following first-line immune-oncology combination therapy.
Journal: World journal of urology
Published: December 15, 2023
Last Updated: 09/26/2026